Two different dosages of yeast derived recombinant hepatitis B vaccines: A comparison of immunogenicity

Vaccine

Volumn 14, Issue 2, 1996, Pages 135-137

  Chiaramonte, M ^a   Majori, S ^b   Ngatchu, T ^a   Moschen, M E ^a   Baldo, V ^a   Renzulli, G ^c   Simoncello, I ^c   Rocco, S ^c   Bertin, T ^a   Naccarato, R ^a   Trivello, R ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c Padua Local Health Authority   (Italy)

Author keywords

HB vaccine; HBV; Immunogenicity; Recombinant vaccines

Indexed keywords

HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADULT; AGE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE; DRUG EFFICACY; FEMALE; GENDER; HEPATITIS B; HUMAN; IMMUNIZATION; IMMUNOGENICITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030048256     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00148-T     Document Type: Article

References (8)

1. Wainwright, R.B., McMahon, B.J., Bulkow, L.R. et al. Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population. J. Am. Med. Assoc. 1989, 261, 2362-2366
2. Davidson, M. and Krugman, S. Immunogenicity of recombinant yeast hepatitis B vaccine. Lancet 1985, 1, 108-109
3. Dentico, P., Buongiorno, R., Volpe, A., Zavoianni, A., Pastore, G. and Schiraldi, O. Long term immunogenicity, safety and efficacy of a recombinant hepatitis B vaccine in healthy adults. Eur. J. Epidemiol. 1992, 8, 650-655
4. Hammond, G.W., Parker, J., Mimms, L., Tate, R., Sekla, L. and Minuk, G. Comparison of immunogenicity of two yeast derived recombinant hepatitis B vaccines. Vaccine 1991, 9, 97-100
5. Schmid, K., Strebl, H., Heck, K.J., Weltle, D. and Raithel, H.J. Efficacy and tolerance of hepatitis B vaccines produced by gene technology - a comparative review. Gesundheitswesen 1992, 54, 219-222
6. Jilg, W., Schmidt, M. and Deinhardt, F. Persistence of specific antibodies after hepatitis B vaccination. J. Hepat. 1988, 6, 201-207
7. Möst, J., Larcher, C., Vogetseder, W. et al. Recombinant versus plasma-derived hepatitis B vaccine: comparison of immunogenicity in medical students. Vaccine 1992, 10, 740-741
8. Trivello, R., Chiaramonte, M., Ngatchu, T. et al. Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine. Vaccine 1995, 13, 139-141